Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He is currently finishing up a Master’s degree in communications at Georgetown University.

Latest Posts

Innovation Files: CSBI Tax Proposals Attempt to Bridge “Valley of Death”

CSBI-logo

Over at the Innovation Files, Joe Kennedy has posted an excellent summary of a set of tax reform proposals developed by the Coalition of Small Business Innovators (CSBI), of which BIO is a member. The proposals would increase investment and employment at small, research intensive companiesby allowing investors to take advantage of passive losses and research credits generated by the company. They would also allow companies to carry net operating losses forward to future years Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Voting Opens for Everyday Superhero Contest

BIO-InternationalConvention_Graphic_115x176_v3

Earlier this month, members of the biotech community nominated their best and brightest colleagues who are striving to heal, fuel, and feed the world through groundbreaking innovation. Now it is your turn to vote for your favorite BIO Superhero in each of the three categories: Biotech/Pharma, Patient/Patient Group, and University/Research Institution. One vote per email address, per day will be strictly enforced. The individuals with the most votes in each category will win a complimentary Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Upcoming Webinar: The Future of Partnering

Partnering-HP-Banner

We’ve talked before about the new and improved BIO One-on-One™ partnering system coming for BIO 2015. To give you a sneak peak at the new system, BIO and INOVA are co-hosting a webinar on Thursday, March 19th from 11:00 am – 11:45 am EDT. To RSVP for tomorrow’s webinar, please click here. Find more information about BIO One-on-One Partnering, including upcoming webinars and training events, at convention.bio.org/partner. INOVA and BIO have teamed up to create Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

CDC Report: C. diff Infections Associated with 29,000 Deaths per Year in US; Vaccines Could Provide Solution

MRSA

Last month, the CDC released a new study on the impact of microbial super bug Clostridium difficile (C. diff) with some very disturbing findings. The study found that 29,000 deaths in the U.S. were associated with the bug in 2011, and nearly half a million Americans suffered infections. About half of those deaths, or 15,000, were estimated to be directly attributable to the infection. Elderly patients are most vulnerable to C. diff infections, with over Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO’s Dave Thomas Talks VC Funding with Daniel Levine

72263479

Last week, BIO Industry Analysis’s Dave Thomas spoke with Daniel Levine for his weekly podcast, The Bio Report. Dave discussed BIO‘s Venture Funding of Therapeutic Innovation Report, of which he is the lead author. The report analyzes data from four venture capital databases – Thomson Reuters, BioCentury, Elsevier, and Evaluate Pharm – to investigate investor trends, examine investment in specific therapeutic areas and indications, and identify disease areas that might be struggling for early-stage venture Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,